Dentons Paris advised ImCheck Therapeutics on the transaction. McDermott Will & Emery advised McDermott advised EarlyBird and Andera Partners. Goodwin advised Bpifrance. Bpifrance, through its InnoBio...
You must be a Standard 1 Year member to access this content.
Gide advised Goldman Sachs and SVB Leerink LLC. McDermott Will & Emery advised DBV Technologies. DBV Technologies, a clinical-stage biopharmaceutical company, announced a private placement financing...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised Owkin on the deal. French American startup Owkin, which develops artificial intelligence solutions for medical research, entered into a multi-year...
You must be a Standard 1 Year member to access this content.
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Joseph Marx (Equity Capital Markets),...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Dynacure on the deal. Dynacure, a clinical-stage company focused on developing and commercializing innovative therapies to transform the lives of patients...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery and Latham & Watkins advised Owkin on the deal. Covington & Burling LLP advised Sanofi. Owkin, an artificial intelligence and precision medicine...
You must be a Standard 1 Year member to access this content.
McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures. Egle Therapeutics,...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Pierre Fabre on the deal. Pierre Fabre finalized a strategic collaboration with Atara Biotherapeutics to commercialize Tab-cel® in Europe, the Middle East,...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...
You must be a Standard 1 Year member to access this content.
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Pierre Fabre S.A. with a team including Emmanuelle Trombe (Picture –...
You must be a Standard 1 Year member to access this content.
